14 completed, 13 recruiting, 6 terminated, 5 active not recruiting. 46 Phase 2, 4 Phase 1, 2 Phase 3.
Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-12-18 | 2026-09-30 |
| Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors Biospecimen Collection, Cannabidiol, Dronabinol - Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Recruiting | City of Hope Medical Center | 120 | 2025-10-03 | 2025-12-05 |
| Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | City of Hope Medical Center | 82 | 2025-08-28 | 2026-10-30 |
| Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction Biospecimen Collection, Mammography, Omega-3-Acid Ethyl Esters - Breast Atypical Hyperplasia, Breast Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 66 | 2025-07-28 | 2026-08-04 |
| Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer Biopsy of Breast, Biospecimen Collection, Breast Surgery - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 120 | 2025-05-14 | 2026-09-03 |
| Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer Biospecimen Collection, Oligo-fucoidan, Placebo Administration - Malignant Digestive System Neoplasm, Malignant Female Reproductive System Neoplasm | Phase 2 | Recruiting | Mayo Clinic | 34 | 2025-03-06 | 2026-10-16 |
| Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer Acolbifene Hydrochloride, Biospecimen Collection, Mammography - Breast Atypical Hyperplasia, Breast Carcinoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 80 | 2024-10-10 | 2026-11-18 |
| Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial Biopsy Procedure, Biospecimen Collection, Mammography - Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 200 | 2024-09-27 | 2026-07-27 |
| TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Breast Cancer, Breast Carcinoma | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 85 | 2024-08-22 | 2024-11-12 |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy Tart Cherry Juice - Breast Cancer, Breast Cancer Stage I | Phase 2 | Recruiting | University of California, Davis | 86 | 2024-08-15 | 2026-03-04 |
| EMBRACE: Exercising Together Exercise Intervention, Biospecimen Collection, Educational Intervention - Breast Carcinoma, Prostate Carcinoma | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 400 | 2024-04-18 | 2026-10-13 |
| Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy Alginos Oral Suspension - Breast Carcinoma | Phase 2 | Enrolling by invitation | Taipei City Hospital | 90 | 2024-02-15 | 2025-05-06 |
| Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy eftilagimod alpha, Paclitaxel, placebo - Breast Carcinoma | Phase 2 / Phase 3 | Terminated | Immutep S.A.S. | 72 | 2023-05-22 | 2026-07-30 |
| Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration - Breast Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 60 | 2023-03-09 | 2026-10-01 |
| A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer Computed Tomography, Fluorine F 18 Fluorthanatrace, Positron Emission Tomography - Breast Carcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 36 | 2023-02-27 | 2026-06-12 |
| Study of Aerobic Training for People Receiving Treatment for Breast Cancer Adaptive Aerobic Training/AT Dosing, Standard (fixed) Aerobic Training/AT dosing - Breast Cancer, Breast Carcinoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 140 | 2023-01-30 | 2026-08-27 |
| Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC NUV-422, Fulvestrant - Advanced Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2023-07-11 | |
| Therapeutic Dose Monitoring (TDM) of Tamoxifen Tamoxifen 20 mg - Breast Cancer, Breast Carcinoma | Phase 2 | Unknown | Karolinska University Hospital | 40 | 2022-04-04 | 2022-05-25 |
| Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer Anastrozole 1mg, Letrozole 2.5mg, Exemestane 25 mg - Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Completed | Irada Ibrahim-zada | 8 | 2022-02-18 | 2026-08-31 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel Cimetidine, Dexamethasone, Diphenhydramine - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 / Phase 3 | Completed | Ohio State University Comprehensive Cancer Center | 130 | 2021-10-07 | 2025-08-20 |
Showing 20 of 46. Sign in to see all of them.
Breast Neoplasms (46) · Breast Carcinoma In Situ (6) · Ovarian Neoplasms (5) · Triple Negative Breast Neoplasms (4) · Carcinoma, Intraductal, Noninfiltrating (3) · Lung Neoplasms (3) · Prostatic Neoplasms (3) · Uterine Cervical Neoplasms (3) · Carcinoma, Hepatocellular (2) · Carcinoma, Renal Cell (2) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Endometrial Neoplasms (2) · Fallopian Tube Neoplasms (2) · Hematologic Neoplasms (2)
Breast Diseases (46) · Neoplasms (46) · Neoplasms by Site (46) · Skin Diseases (46) · Skin and Connective Tissue Diseases (46) · Neoplasms by Histologic Type (10) · Carcinoma (9) · Neoplasms, Glandular and Epithelial (9) · Carcinoma in Situ (6) · Genital Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Adenocarcinoma (5) · Adnexal Diseases (5) · Digestive System Diseases (5)
Specimen Handling (9) · Tamoxifen (7) · Paclitaxel (6) · Letrozole (5) · Fulvestrant (4) · Magnetic Resonance Spectroscopy (4) · Trastuzumab (4) · palbociclib (4) · Biopsy (3) · Carboplatin (2) · Goserelin (2) · MLN 8237 (2) · Mastectomy, Segmental (2) · Nivolumab (2) · Taxes (2)
Mayo Clinic (6) · National Cancer Institute (NCI) (4) · City of Hope Medical Center (2) · M.D. Anderson Cancer Center (2) · OHSU Knight Cancer Institute (2) · Washington University School of Medicine (2) · Academic and Community Cancer Research United (1) · American Scitech International (1) · Andrei Iagaru (1) · Antisoma Research (1) · Catalysis SL (1) · Clinique Clementville (1) · Dawn L. Hershman (1) · Essen Biotech (1) · Gary Morrow (1)
United States (37) · Belgium (1) · Canada (1) · China (1) · Cuba (1) · France (1) · Georgia (1) · Guam (1) · Moldova (1) · Puerto Rico (1) · Russia (1) · Spain (1) · Sweden (1) · Taiwan (1) · United Kingdom (1)
Amy Degnim, M.D. (1) · Andrei Iagaru (1) · Azadeh Nasrazadani (1) · Carlos E. Vargas, MD (1) · Carol J Fabian (1) · Charles Loprinzi (1) · Cynthia X Ma, M.D., Ph.D. (1) · David B. Page, MD (1) · Dawn Hershman, MD, MS (1) · Debra Barton (1) · Dennis Holmes (1) · Elham Hedayati, MD PhD (1) · Eve Rodler, MD (1) · Foluso O Ademuyiwa, M.D, MPH (1)
PMID 21878535, PMID 26586415, PMID 30347019, PMID 32463741, PMID 33048619, PMID 33877311, PMID 34882500, PMID 35133871, PMID 35138919, PMID 35314693, PMID 36351402, PMID 36410913, PMID 36609389, PMID 37053535, PMID 37322121, PMID 37934000, PMID 38591867, PMID 39558017, PMID 39666929, PMID 39693587, PMID 39913886, PMID 40443562, PMID 40865033, PMID 41066729
UG1CA242632 (3), P30CA033572 (2), P30CA046592 (2), 2009 (1), P30CA014520 (1), P30CA015083 (1), P30CA060553 (1), P30CA069533 (1), R01CA237607 (1), R01CA258717 (1), R01CA262393 (1), R01CA277738 (1), R21CA178648 (1), U01CA168426 (1), U10CA180820 (1)